HomeTLX • ASX
add
Telix Pharmaceuticals Ltd
Previous close
$22.20
Day range
$22.43 - $22.93
Year range
$9.06 - $23.99
Market cap
7.56B AUD
Avg Volume
962.38K
P/E ratio
150.84
Dividend yield
-
Primary exchange
ASX
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 188.96M | 58.05% |
Operating expense | 92.39M | 161.35% |
Net income | 11.68M | 300.41% |
Net profit margin | 6.18 | 226.90% |
Earnings per share | — | — |
EBITDA | 20.37M | -47.25% |
Effective tax rate | -27.75% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 118.84M | -9.79% |
Total assets | 745.96M | 140.37% |
Total liabilities | 341.98M | 45.97% |
Total equity | 403.97M | — |
Shares outstanding | 334.23M | — |
Price to book | 18.35 | — |
Return on assets | 7.63% | — |
Return on capital | 14.32% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 11.68M | 300.41% |
Cash from operations | 33.61M | 210.88% |
Cash from investing | -36.93M | -2,854.32% |
Cash from financing | 3.62M | 29.26% |
Net change in cash | -3.87M | -137.31% |
Free cash flow | 104.20M | — |
About
Founded
2015
Website
Employees
423
